THE WHAT Estée Lauder Companies has reported a record Q2 fiscal 2022, with sales up 14 percent, bolstered by a market recovery in Western markets and strong online sales.
THE DETAILS Reporting US$4.85 billion in sales, ELC saw earnings of US$1.09 billion, up from US$870 million YOY.
Skincare sales rose 12 percent YOY during the quarter to US$3.2billion, with La Mer and Clinique reporting double digit growth.
Make-up sales hit US$1.4 billion, up 11 percent, however, failed to reach pre-pandemic levels. Estée Lauder, MAC, Too Faced, Tom Ford Beauty, Smashbox, Estée Lauder’s Double Wear and Futurist foundation were all reported to have done well.
Achieving 29 percent growth, fragrance sales hit US$799 million, driven by Jo Malone, Tom Ford and Kilian Paris. Hair sales increased 17 percent to US$180 million.
Looking at regional growth, the Americas saw a 24 percent YOY increase to US$1.3 billion in sales, while Europe, the Middle East and Africa rose 15 percent to US$2.3 billion.
Asia Pacific was driven by China, reporting a 7 percent rise to US$1.9 billion.
THE WHY ELC President and CEO Fabrizio Freda said, “We achieved record sales and profitability in the second quarter of fiscal 2022, empowered by the timeless desirability of our brands and despite accelerated volatility and variability, as well as supply chain challenges, from the pandemic.
“Every category, region and major channel expanded, showcasing the strength of our multiple engines of growth strategy. We seized the favorable dynamics of skin care, fragrances, developed markets in the West and brick-and-mortar, and continued to prosper in the East with Chinese consumers, as well as in global travel retail and global online.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
